GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 204 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2022. The put-call ratio across all filers is 1.05 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $21,441,000 | +292.9% | 314,839 | +84.3% | 0.07% | +305.6% |
| Q2 2022 | $5,457,000 | -64.0% | 170,798 | -61.0% | 0.02% | -60.0% |
| Q1 2022 | $15,175,000 | +170.7% | 438,080 | +128.8% | 0.04% | +275.0% |
| Q4 2021 | $5,605,000 | -59.0% | 191,505 | +11.4% | 0.01% | -70.7% |
| Q4 2019 | $13,666,000 | – | 171,922 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 595,473 | $25,790,000 | 4.19% |
| Grace Capital | 131,549 | $5,697,000 | 3.60% |
| Fernwood Investment Management, LLC | 201,657 | $8,734,000 | 3.44% |
| Fairmount Funds Management LLC | 215,000 | $9,312,000 | 3.33% |
| Arctis Global LLC | 293,700 | $12,720,000 | 2.74% |
| Perceptive Advisors | 5,674,711 | $245,771,000 | 2.64% |
| ArchPoint Investors | 217,510 | $9,420,000 | 2.61% |
| Alerce Investment Management, L.P. | 126,270 | $5,469,000 | 2.15% |
| Profit Investment Management, LLC | 42,196 | $1,826,000 | 1.17% |
| Affinity Asset Advisors, LLC | 50,000 | $2,166,000 | 1.15% |